MB

Michael Baker

Dr Baker has over 20 years of experience in scientific research, drug development and venture investment. He was an Investment Manager with Australian life science fund, BioScience Managers, responsible for deal sourcing from networks, conferences, universities, and research institutes. He also conducted due diligence to shortlist investment opportunities and played an active role in managing portfolio companies.

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
04/05/2608,184,4935,668,280N/A
08/12/23N/A117,4111,906,262N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
10/11/25
Issued
1,831,266$0.089$162,982Issue of options
13/10/25
Expiry
6,382,979$0.094$600,000Options expired
13/10/25
Issued
1,617,021$0.075$121,276Exercise of options
13/10/25
Exercise
1,617,021$0.075$121,276Exercise of options
26/11/24
Issued
1,658,483$0.185$306,819Director remuneration